• Home
  • About Us
    • Who We Are
    • PRIM&R Partners
    • Resources
    • Ampersand Blog
    • Career Center
  • Conference
    • Past Conferences
    • Ampersand 2024 Proceedings
    • Exhibit 2026
  • Certification
    • Eligibility
    • CIP Resources
    • CPIA Resources
    • Certification Exams
    • CIP and CPIA Councils
    • CIP and CPIA Recertification
  • Programs
    • Education at PRIM&R
    • AI Education Bundle
    • Flash Learn
    • Workshops
    • Seminars
    • Symposium
    • Panel
    • Courses
    • Webinars
    • Certificates
  • Membership
    • Member Benefits
    • Member Hub
  • Understanding Research
    • Research Ethics Timeline
    • Lead the Way
    • Research Ethics Reimagined Podcast
    • People and Perspectives
  • Public Policy
    • Research Ethics in Public Policy
    • Advocacy Toolkit
    • Resources
    • Federal Public Policy Briefings
    • Policy Comments
  • Support Us
    • Donate
    • Volunteer
    • Sponsor
    • Bookstore
  • Policies
    • PRIM&R Policy
    • Events Code of Conduct
    • Reporting Misconduct
  • Blog
login

SACHRP Recommendations

April 7, 2020 - Letter to the HHS Secretary

April 7, 2020

The Honorable Alex M. Azar II
Secretary of Health and Human Services
200 Independence Avenue S.W.
Washington, D.C. 20201

Recommendation Letter RE: Providing New Information to Previously Enrolled Research Subjects and Clarifying Requirements in Digital Health Technologies Research: End-User License Agreements (EULAs) and Terms of Service (ToS) and Their Relation to Study Consent and to IRB and Investigator Roles

Dear Mr. Azar:
On behalf of the Secretary's Advisory Committee on Human Research Protections (SACHRP), I respectfully submit for your consideration recommendations relevant to the Department of Health and Human Services (HHS) human subjects protection regulations at 45 CFR part 46. These recommendations were presented to SACHRP by SACHRP's Subcommittee on Harmonization and Subpart A Subcommittee, and were approved at the meeting held March 11-12, 2020.
  • Providing New Information to Previously Enrolled Research Subjects (Attachment A)
  • Clarifying Requirements in Digital Health Technologies Research: End-User License Agreements (EULAs) and Terms of Service (ToS) and Their Relation to Study Consent and to IRB and Investigator Roles (Attachment B)
On behalf of SACHRP, I would like to thank you for your consideration of theses recommendations. The committee, the Subpart A. Subcommittee and the Subcommittee on Harmonization have been actively working in pursuit of their charges, and remain dedicated to continuing this work to enhance human subjects protections for the benefit of all Americans.
Sincerely, /s/
Stephen Rosenfeld, M.D.Chair, Secretary's Advisory Committeeon Human Research Protections(SACHRP)
Enc.
cc: Jerry Menikoff, M.D., J.D., Executive Secretary, SACHRPJulia Gorey, J.D., Executive Director, SACHRP

Related Recommendations

Attachment A2 - Reconsent Appendix 2Attachment A1 - Reconsent Appendix 1Attachment B - Clarifying Requirements in Digital Health Technologies ResearchAttachment A - New Information Provided to Previously Enrolled Research Subjects
Content created by Office for Human Research Protections (OHRP)Content last reviewed April 24, 2020

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.